Affiliation:
1. Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA 92182, U.S.A.
Abstract
AbstractEnzymes have evolved to catalyze their precise reactions at the necessary rates, locations, and time to facilitate our development, to respond to a variety of insults and challenges, and to maintain a healthy, balanced state. Enzymes achieve this extraordinary feat through their unique kinetic parameters, myriad regulatory strategies, and their sensitivity to their surroundings, including substrate concentration and pH. The Cancer Genome Atlas (TCGA) highlights the extraordinary number of ways in which the finely tuned activities of enzymes can be disrupted, contributing to cancer development and progression often due to somatic and/or inherited genetic alterations. Rather than being limited to the domain of enzymologists, kinetic constants such as kcat, Km, and kcat/Km are highly informative parameters that can impact a cancer patient in tangible ways—these parameters can be used to sort tumor driver mutations from passenger mutations, to establish the pathways that cancer cells rely on to drive patients’ tumors, to evaluate the selectivity and efficacy of anti-cancer drugs, to identify mechanisms of resistance to treatment, and more. In this review, we will discuss how changes in enzyme activity, primarily through somatic mutation, can lead to altered kinetic parameters, new activities, or changes in conformation and oligomerization. We will also address how changes in the tumor microenvironment can affect enzymatic activity, and briefly describe how enzymology, when combined with additional powerful tools, and can provide us with tremendous insight into the chemical and molecular mechanisms of cancer.
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference147 articles.
1. Die kinetik der invertinwirkung;Michaelis;Biochem. Z.,1913
2. Clinical significance of enzymes in disease and diagnosis;Fahad Ullah,2019
3. The Cancer Genome Atlas Pan-Cancer analysis project;Cancer Genome Atlas Research Network;Nat. Genet.,2013
4. Drug-target kinetics in drug discovery;Tonge;ACS Chem. Neurosci.,2018
5. Mechanistic enzymology in drug discovery: a fresh perspective;Holdgate;Nat. Rev. Drug Discov.,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献